Dennis A. Revicki

Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients

D. Revicki, J. Panish, R. Dirani, 2010, Schizophrenia Research.

Reliability and validity of a health-related quality of life battery for evaluating outpatient antidepressant treatment

D. Revicki, R. Brown, R. Turner, 1992, Quality of Life Research.

Impact of adalimumab treatment on health‐related quality of life and other patient‐reported outcomes: results from a 16‐week randomized controlled trial in patients with moderate to severe plaque psoriasis

J. Saurat, J. Ortonne, K. Papp, 2007, The British journal of dermatology.

Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.

Ruth E. Brown, M. Keller, D. Revicki, 1997, The Journal of clinical psychiatry.

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.

M. Rudnick, B. Freedman, T. Steinman, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Responsiveness and calibration of the General Well-Being Adjustment Scale in patients with hypertension.

D. Revicki, K. Bungay, G. Williams, 1994, Journal of clinical epidemiology.

Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index

C. Thompson, N. Leidy, D. Revicki, 1998, Quality of Life Research.

Calibration of the Dutch‐Flemish PROMIS Pain Behavior item bank in patients with chronic pain

L. Roorda, H. Vet, K. Cook, 2016, European journal of pain.

Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index‐Daily Diary (GCSI‐DD)

B. Kuo, H. Parkman, L. Szarka, 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.